These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 18799581)

  • 1. Asymptomatic human CD4+ cytotoxic T-cell epitopes identified from herpes simplex virus glycoprotein B.
    Chentoufi AA; Binder NR; Berka N; Durand G; Nguyen A; Bettahi I; Maillère B; BenMohamed L
    J Virol; 2008 Dec; 82(23):11792-802. PubMed ID: 18799581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Epitopes Identified from Herpes Simplex Virus Tegument Protein VP11/12 (UL46) Recall Multifunctional Effector Memory CD4
    Srivastava R; Coulon PA; Prakash S; Dhanushkodi NR; Roy S; Nguyen AM; Alomari NI; Mai UT; Amezquita C; Ye C; Maillère B; BenMohamed L
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31915285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunodominant epitopes in herpes simplex virus type 2 glycoprotein D are recognized by CD4 lymphocytes from both HSV-1 and HSV-2 seropositive subjects.
    Kim M; Taylor J; Sidney J; Mikloska Z; Bodsworth N; Lagios K; Dunckley H; Byth-Wilson K; Denis M; Finlayson R; Khanna R; Sette A; Cunningham AL
    J Immunol; 2008 Nov; 181(9):6604-15. PubMed ID: 18941251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymptomatic HLA-A*02:01-restricted epitopes from herpes simplex virus glycoprotein B preferentially recall polyfunctional CD8+ T cells from seropositive asymptomatic individuals and protect HLA transgenic mice against ocular herpes.
    Dervillez X; Qureshi H; Chentoufi AA; Khan AA; Kritzer E; Yu DC; Diaz OR; Gottimukkala C; Kalantari M; Villacres MC; Scarfone VM; McKinney DM; Sidney J; Sette A; Nesburn AB; Wechsler SL; BenMohamed L
    J Immunol; 2013 Nov; 191(10):5124-38. PubMed ID: 24101547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes.
    Mikloska Z; Cunningham AL
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():353-61. PubMed ID: 9472620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and functional characterization of herpes simplex virus glycoprotein B epitope-specific effector and memory CD8+ T cells from symptomatic and asymptomatic individuals with ocular herpes.
    Khan AA; Srivastava R; Spencer D; Garg S; Fremgen D; Vahed H; Lopes PP; Pham TT; Hewett C; Kuang J; Ong N; Huang L; Scarfone VM; Nesburn AB; Wechsler SL; BenMohamed L
    J Virol; 2015 Apr; 89(7):3776-92. PubMed ID: 25609800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity.
    BenMohamed L; Bertrand G; McNamara CD; Gras-Masse H; Hammer J; Wechsler SL; Nesburn AB
    J Virol; 2003 Sep; 77(17):9463-73. PubMed ID: 12915561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender-dependent HLA-DR-restricted epitopes identified from herpes simplex virus type 1 glycoprotein D.
    Zhang X; Castelli FA; Zhu X; Wu M; Maillère B; BenMohamed L
    Clin Vaccine Immunol; 2008 Sep; 15(9):1436-49. PubMed ID: 18667634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpesvirus Infection.
    Srivastava R; Khan AA; Garg S; Syed SA; Furness JN; Vahed H; Pham T; Yu HT; Nesburn AB; BenMohamed L
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-A*0201-restricted CD8+ cytotoxic T lymphocyte epitopes identified from herpes simplex virus glycoprotein D.
    Chentoufi AA; Zhang X; Lamberth K; Dasgupta G; Bettahi I; Nguyen A; Wu M; Zhu X; Mohebbi A; Buus S; Wechsler SL; Nesburn AB; BenMohamed L
    J Immunol; 2008 Jan; 180(1):426-37. PubMed ID: 18097044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
    Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L
    J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant.
    Wallace ME; Keating R; Heath WR; Carbone FR
    J Virol; 1999 Sep; 73(9):7619-26. PubMed ID: 10438852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DR and HLA-DP restricted epitopes from human cytomegalovirus glycoprotein B recognized by CD4+ T-cell clones from chronically infected individuals.
    Ventura C; Bisceglia H; Girerd-Chambaz Y; Burdin N; Chaux P
    J Clin Immunol; 2012 Dec; 32(6):1305-16. PubMed ID: 22797815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunodominant "asymptomatic" herpes simplex virus 1 and 2 protein antigens identified by probing whole-ORFome microarrays with serum antibodies from seropositive asymptomatic versus symptomatic individuals.
    Dasgupta G; Chentoufi AA; Kalantari M; Falatoonzadeh P; Chun S; Lim CH; Felgner PL; Davies DH; BenMohamed L
    J Virol; 2012 Apr; 86(8):4358-69. PubMed ID: 22318137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of B- and T-cell epitopes from glycoprotein B of herpes simplex virus 2 and evaluation of their immunogenicity and protection efficacy.
    Liu K; Jiang D; Zhang L; Yao Z; Chen Z; Yu S; Wang X
    Vaccine; 2012 Apr; 30(19):3034-41. PubMed ID: 22008818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Asymptomatic Epitope Peptide/CXCL10-Based Prime/Pull Vaccine Induces Herpes Simplex Virus-Specific Gamma Interferon-Positive CD107
    Khan AA; Srivastava R; Vahed H; Roy S; Walia SS; Kim GJ; Fouladi MA; Yamada T; Ly VT; Lam C; Lou A; Nguyen V; Boldbaatar U; Geertsema R; Fraser NW; BenMohamed L
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29899087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions.
    Koelle DM; Corey L; Burke RL; Eisenberg RJ; Cohen GH; Pichyangkura R; Triezenberg SJ
    J Virol; 1994 May; 68(5):2803-10. PubMed ID: 7512152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of an immunodominant herpes simplex virus type 1 CD8+ T cell epitope on the target hierarchy and function of subdominant CD8+ T cells.
    Treat BR; Bidula SM; Ramachandran S; St Leger AJ; Hendricks RL; Kinchington PR
    PLoS Pathog; 2017 Dec; 13(12):e1006732. PubMed ID: 29206240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Herpes Simplex Virus Type 1 Human Asymptomatic CD8+ T-Cell Epitopes-Based Vaccine Protects Against Ocular Herpes in a "Humanized" HLA Transgenic Rabbit Model.
    Srivastava R; Khan AA; Huang J; Nesburn AB; Wechsler SL; BenMohamed L
    Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):4013-28. PubMed ID: 26098469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD.
    Zarling JM; Moran PA; Burke RL; Pachl C; Berman PW; Lasky LA
    J Immunol; 1986 Jun; 136(12):4669-73. PubMed ID: 2423598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.